Abstract
This study reveals the different effectiveness of xylazine in mules compared with horses. Fourteen adult mules (mean body weight ± standard deviation, 466 ± 89 kg) and six adult Haflinger horses (483 ± 39 kg) chosen from a single livestock operation in Germany received 0.6 mg of the α2-agonist xylazine administered intravenously per kilogram of body weight. Principal pharmacokinetic and pharmacodynamic parameters were determined while the animals received a routine dental treatment. To objectively assess the depth of sedation, a variety of behavioral and clinical parameters were assessed and transferred to a scaled score system. Compared with the Haflinger horses, the depth of sedation in mules differed significantly between 10 and 45 minutes after xylazine administration. In the mule, sedation was good during the first 10 minutes, moderate at 15 minutes, and insufficient at 30 minutes. In the horse, sedation was excellent during the first 15 minutes, moderate at 30 minutes, and insufficient at 45 minutes. Moreover, significant (P < .05) subspecies differences in the pharmacokinetics of xylazine were detected between the mules and the horses. Data analysis followed the two-compartment model, which had a correlation with the measured data of R² = .99. Values for t1/2β (half-life during elimination), mean residence time, mean residence time(0-tz) (residence time on last measuring time point above limit of quantification), k21 (velocity constant for distribution from peripheral to central compartment), β (velocity constant during elimination), and B (relative y-intercept) varied significantly between the two subspecies.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call